Skip to main content
  • Retraction Note
  • Open access
  • Published:

Retraction Note to: Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway

The Original Article was published on 26 June 2017

Retraction note to: Mol Cancer 16, 110 (2017)

https://doi.org/10.1186/s12943-017-0677-9.

The Editor-in-Chief has retracted this article. After publication, concerns were raised regarding partial image overlap in Figs.1, 2 and 5–7. The Editor-in-Chief therefore no longer has confidence in the presented data.

Yunhui Liu has stated on behalf of all co-authors that they do not agree to this retraction.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yunhui Liu.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doi.org/10.1186/s12943-017-0677-9.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yu, M., Xue, Y., Zheng, J. et al. Retraction Note to: Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway. Mol Cancer 21, 188 (2022). https://doi.org/10.1186/s12943-022-01660-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12943-022-01660-3